BMX-IN-1 is primarily used in biochemical research as a selective inhibitor targeting specific kinase pathways. It is particularly valuable in studying cellular signaling mechanisms, especially those involving BMX (Bone Marrow X kinase) and its role in cancer progression and immune responses. Researchers utilize BMX-IN-1 to investigate its potential therapeutic effects in inhibiting tumor growth and metastasis, particularly in cancers where BMX overexpression is observed. Additionally, it aids in exploring the molecular basis of inflammatory diseases and immune regulation, providing insights for developing targeted therapies. Its application extends to in vitro and in vivo studies to evaluate efficacy, selectivity, and safety profiles in preclinical models.